Inventor
BREKKEN ROLF A
US17 patents
⚠️ This page may combine multiple inventors who share the name “BREKKEN ROLF A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV TEXAS
15 patentsUS7056509B2Jun 6, 2006
Antibody methods for selectively inhibiting VEGF
UNIV TEXAS77 citations99
US6887468B1May 3, 2005
Antibody kits for selectively inhibiting VEGF
UNIV TEXAS70 citations99
US6818213B1Nov 16, 2004
Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids
UNIV TEXAS95 citations99
US6703020B1Mar 9, 2004
Antibody conjugate methods for selectively inhibiting VEGF
UNIV TEXAS296 citations99
US6676941B2Jan 13, 2004
Antibody conjugate formulations for selectively inhibiting VEGF
UNIV TEXAS144 citations99
US6524583B1Feb 25, 2003
Antibody methods for selectively inhibiting VEGF
UNIV TEXAS215 citations99
US6416758B1Jul 9, 2002
Antibody conjugate kits for selectively inhibiting VEGF
UNIV TEXAS153 citations99
US6342221B1Jan 29, 2002
Antibody conjugate compositions for selectively inhibiting VEGF
UNIV TEXAS354 citations99
US6342219B1Jan 29, 2002
Antibody compositions for selectively inhibiting VEGF
UNIV TEXAS651 citations99
US6783760B1Aug 31, 2004
Combined cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
UNIV TEXAS87 citations98
US7067109B1Jun 27, 2006
Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids
UNIV TEXAS57 citations96
US7790860B2Sep 7, 2010
Targeting and imaging tumor vasculature using conjugates that bind to aminophospholipids
UNIV TEXAS15 citations92
US7550141B2Jun 23, 2009
Methods for imaging tumor vasculature using conjugates that bind to aminophospholipids
UNIV TEXAS12 citations84
US10370360B2Aug 6, 2019
Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof
UNIV TEXAS3 citations68
US9986723B2Jun 5, 2018
Screen and use of therapeutics for pancreatic ductal adenocarcinoma
UNIV TEXAS4 citations65